Your browser doesn't support javascript.
loading
Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.
Garcia, Raul; Cotter, Austin R; Leslie, Kenneth; Olive, M Foster; Neisewander, Janet L.
Affiliation
  • Garcia R; School of Life Sciences (Mr Garcia, Mr Cotter, Mr Leslie, and Dr Neisewander), and Psychology Department (Dr Olive), Arizona State University, Tempe, Arizona.
  • Cotter AR; School of Life Sciences (Mr Garcia, Mr Cotter, Mr Leslie, and Dr Neisewander), and Psychology Department (Dr Olive), Arizona State University, Tempe, Arizona.
  • Leslie K; School of Life Sciences (Mr Garcia, Mr Cotter, Mr Leslie, and Dr Neisewander), and Psychology Department (Dr Olive), Arizona State University, Tempe, Arizona.
  • Olive MF; School of Life Sciences (Mr Garcia, Mr Cotter, Mr Leslie, and Dr Neisewander), and Psychology Department (Dr Olive), Arizona State University, Tempe, Arizona.
  • Neisewander JL; School of Life Sciences (Mr Garcia, Mr Cotter, Mr Leslie, and Dr Neisewander), and Psychology Department (Dr Olive), Arizona State University, Tempe, Arizona.
Int J Neuropsychopharmacol ; 20(8): 644-653, 2017 08 01.
Article in En | MEDLINE | ID: mdl-28444326
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amphetamine-Related Disorders / Serotonin 5-HT1 Receptor Agonists Type of study: Prognostic_studies Limits: Animals Language: En Journal: Int J Neuropsychopharmacol Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amphetamine-Related Disorders / Serotonin 5-HT1 Receptor Agonists Type of study: Prognostic_studies Limits: Animals Language: En Journal: Int J Neuropsychopharmacol Year: 2017 Document type: Article